HEAL Act of 2023

This bill updates federal grant programs to include all FDA-approved opioid overdose reversal agents (like naloxone), not just specific products. It requires the Health and Human Services Secretary to revise existing grant program materials by December 2023 to ensure references cover any approved agent. The change directly affects states and tribes receiving State Opioid Response Grants and Tribal Opioid Response Grants under the 21st Century Cures Act, as well as regional/national prevention grants under the Public Health Service Act. This allows grantees greater flexibility to use the most effective, currently available reversal agents in their opioid response efforts.